Company Analysis
Sign in

XORTX Therapeutics Inc. (XRTX)

Nasdaq: XRTX · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.6
◀ Past 5.5● Present 5.1▶ Future 6.2
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

The Form 20-F filed Mar 20, 2026 for the period ended Dec 31, 2025 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Report filedMar 20, 2026May 12, 2025May 10, 2024Apr 28, 2023
Research and development574,935183,8302,418,715·
General and administrative241,032320,949375,505·
Income before income taxes-3,257,847-4,118,319-6,045,986·
Net income-2,656,304-3,313,346-2,158,065·
Earnings per share, basic-0.56-1.15-1.09·
Earnings per share, diluted-0.56-1.15-1.09·
Weighted average shares, basic4,734,6332,878,5141,981,734·
Weighted average shares, diluted4,734,6332,878,5141,981,734·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton XRTX · research, not advice